Skip to main content

Table 3 The associations of SHR with all-cause mortality in patients with AKI

From: Risk analysis and mediation analysis of stress hyperglycemia ratio and all-cause mortality in patients with acute kidney injury

Categories

Model 1

HR (95% CI)

P-value

Model 2

HR (95% CI)

P-value

Model 3

HR (95% CI)

P-value

28-day mortality

      

SHR, Per 1-point increment

1.70 (1.49, 1.94)

<0.001

1.78 (1.56, 2.02)

<0.001

1.77 (1.38, 2.27)

<0.001

SHR (category)

      

 T1 (≤ 0.95)

Ref.

 

Ref.

 

Ref.

 

 T2 (0.95–1.25)

1.35 (1.06, 1.70)

0.013

1.37 (1.08, 1.73)

0.009

1.29 (1.02, 1.66)

0.036

 T3 (> 1.25)

1.94 (1.55, 2.41)

<0.001

2.05 (1.65, 2.56)

<0.001

1.56 (1.18, 2.05)

0.002

P for trend

 

<0.001

 

<0.001

 

0.002

90-day mortality

      

SHR, Per 1-point increment

1.60 (1.39, 1.77)

<0.001

1.66 (1.47, 1.87)

<0.001

1.69 (1.36, 2.11)

<0.001

SHR (category)

      

 T1 (≤ 0.95)

Ref.

 

Ref.

 

Ref.

 

 T2 (0.95–1.25)

1.19 (0.98, 1.45)

0.077

1.22 (1.00, 1.48)

0.050

1.18 (0.96, 1.45)

0.106

 T3 (> 1.25)

1.64 (1.37, 1.98)

<0.001

1.76 (1.46, 2.12)

<0.001

1.42 (1.12, 1.79)

0.003

 P for trend

 

<0.001

 

<0.001

 

0.003

  1. Model 1 was unadjusted.
  2. Model 2 was adjusted for sex, age, and BMI.
  3. Model 3 was adjusted for sex, age, BMI, SOFA, SAPS II, CKD, hypertension, HF, RF, COPD, diabetes, malignancy, diuretics, vasoactive drugs, RRT, WBC, hemoglobin, RDW, platelet, creatinine, BUN, albumin, ALT, AST, TC, TG, potassium, sodium, chlorine, and glucose.